List view / Grid view
Givlaari (givosiran) has been approved by the FDA for the…
Givlaari (givosiran) has been approved by the FDA for the treatment of adult patients with the rare genetic disorder, acute hepatic porphyria.
Adakveo has been approved by the FDA to reduce the…
Adakveo has been approved by the FDA to reduce the frequency of vaso-occlusive crisis, a painful complication of sickle cell disease.
The US Food and Drug Administration (FDA) has granted Orphan…
The US Food and Drug Administration (FDA) has granted Orphan Drug designation to Reblozyl for the treatment of anaemia in adults with beta thalassaemia.
A new initiative has already collaboratively reviewed applications for two…
A new initiative has already collaboratively reviewed applications for two oncology drugs, allowing for simultaneous decisions in three countries.
The US Food and Drug Administration (FDA) has approved Piqray…
The US Food and Drug Administration (FDA) has approved Piqray (alpelisib) tablets to treat patients with breast cancer.
